230 related articles for article (PubMed ID: 33203517)
21. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
22. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
[TBL] [Abstract][Full Text] [Related]
23. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action.
Wan X; Liao J; Lai H; Zhang S; Cui J; Chen C
Front Endocrinol (Lausanne); 2023; 14():1179161. PubMed ID: 37396169
[TBL] [Abstract][Full Text] [Related]
24. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
25. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
Zeng LF; Xiao Y; Sun L
Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
[TBL] [Abstract][Full Text] [Related]
26. TRAIL and EGFR Pathways Targeting microRNAs are Predominantly Regulated in Human Diabetic Nephropathy.
Rai B; Pande A; Tiwari S
Microrna; 2023; 12(2):143-155. PubMed ID: 37098997
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis.
Zha F; Qu X; Tang B; Li J; Wang Y; Zheng P; Ji T; Zhu C; Bai S
Aging (Albany NY); 2019 Jun; 11(11):3716-3730. PubMed ID: 31195367
[TBL] [Abstract][Full Text] [Related]
29. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA Circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy.
Ge X; Xi L; Wang Q; Li H; Xia L; Cang Z; Peng W; Huang S
Gene; 2020 Oct; 758():144952. PubMed ID: 32683074
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.
Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S
Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316
[TBL] [Abstract][Full Text] [Related]
32. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β and Smads.
Lan HY; Chung ACK
Contrib Nephrol; 2011; 170():75-82. PubMed ID: 21659760
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
Simpson K; Wonnacott A; Fraser DJ; Bowen T
Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
[TBL] [Abstract][Full Text] [Related]
35. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
Gao J; Wang W; Wang F; Guo C
Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.
Su J; Ren J; Chen H; Liu B
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611
[TBL] [Abstract][Full Text] [Related]
37. The use of transgenic animals in the study of diabetic kidney disease.
Wogensen L; Krag S; Chai Q; Ledet T
Horm Metab Res; 2005 Apr; 37 Suppl 1():17-25. PubMed ID: 15918106
[TBL] [Abstract][Full Text] [Related]
38. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
[TBL] [Abstract][Full Text] [Related]
40. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
Chen Y; Chen L; Yang T
Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
